Dr. Reid Robison on Novamind’s innovative approach to psychedelic medicine
Novamind’s Chief Medical Officer discusses the growing need for breakthrough mental health treatments and how Novamind is helping to bring psychedelic medicine into everyday healthcare.
Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering
Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.
Novamind Leading The Charge To Deliver Mental Health Alternatives
Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.
Therapy With Substance
Investors are rarely offered an opportunity to participate in a nascent, multi-billion dollar, industry
Novamind's Dr. Reid Robison on Building a Network for Psychedelic Medicine
With years of experience studying and administering ketamine, Dr. Robison discusses psychedelic infrastructure and the change it can create
The Wall Street Reporter Interviewed Novamind's CEO, Yaron Conforti
Yaron Conforti talks to Wall Street Reporter about Novamind's operations and plans for the future